|
|
Development of a novel small molecule, UTL-5g, to treat oxaliplatin-induced throm
|
1R43CA174007-01
|
$276,418
|
$276,418
|
SHAW, JIAJIU
|
21ST CENTURY THERAPEUTICS, INC.
|
|
|
High Throughput 3D Cell Assay for Metastatic Prostate Cancer
|
3R41CA165463-01A1S1
|
$34,628
|
$34,628
|
TAKAYAMA, SHUICHI
|
3D BIOMATRIX, INC.
|
|
|
Sustained, target delivery for treatment of cervical pathologies
|
5R43CA162417-02
|
$45,061
|
$45,061
|
Spencer, WENDY
|
3P BIOTECHNOLOGIES, INC.
|
|
|
SMART Fusion: High Affinity Peptide Capture Reagents
|
N43CO130074-000
|
$199,828
|
$199,828
|
HAYASHI, JUN
|
A&G PHARMACEUTICAL, INC
|
|
|
Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t
|
3R42CA171552-01S1
|
$168,928
|
$168,928
|
Desai, Neil
|
AADI, LLC
|
|
|
Decreasing calories, fat and sodium in restaurant meals for widespread industry a
|
5R44CA150528-03
|
$474,162
|
$474,162
|
HILL, ESTHER
|
ACCENTS ON HEALTH, INC.
|
|
|
Integrated Photoacoustic Ultrasound Real-time Imaging for Brachytherapy Treatment
|
1R43CA180561-01
|
$177,408
|
$177,408
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
|
Targeting B-cell lymphoma with Leukothera
|
3R41CA173900-01S1
|
$108,255
|
$108,255
|
Belinka, Benjamin
|
ACTINOBAC BIOMED, INC.
|
|
|
Actuated Low-Force Biopsy Tool for Versatile Bone Lesion Access with Less Trauma
|
2R44CA139774-02A1
|
$902,610
|
$902,610
|
Mulvihill, Maureen
|
ACTUATED MEDICAL, INC.
|
|
|
Biodegradable Drug-Eluting Surgical Meshes with Tunable Release Kinetics
|
1R43CA167843-01A1
|
$235,568
|
$235,568
|
Wolinsky, Jesse
|
ACUITYBIO CORPORATION
|
|
|
An Immune Repertoire Deep Sequencing Companion Diagnostic for lpilimumab
|
N43CA130037-000
|
$266,199
|
$266,199
|
RIEDER, MARK
|
ADAPTIVE BIOTECHNOLOGIES CORPORATION
|
|
|
Minimal Residual Disease Monitoring by T-cell Receptor Repertoire Profiling
|
1R43CA167972-01A1
|
$165,191
|
$165,191
|
RIEDER, MARK
|
ADAPTIVE TCR CORPORATION
|
|
|
Operation and Maintenance of the Biological Data Processing System
|
N02CM100009-008
|
$818,530
|
$818,530
|
TEKLU, YOHANESS
|
ADDIS INC:1108540
|
|
|
IeDEA West -Africa collaboration
|
4U01AI069919-08
|
$225,000
|
$225,000
|
Dabis, Francois
|
ADERA
|
|
|
The development of a microscopy-based cell-array toxicity assay for quantifying C
|
1R33CA174616-01A1
|
$186,751
|
$186,751
|
Hsiao, Shih-Chia
|
ADHEREN, INC.
|
|
|
Data acquisition system for multiplex analysis of color encoded particles
|
3R42CA140109-04S1
|
$191,250
|
$191,250
|
Gorbovitski, Boris
|
ADVANCED BIOMEDICAL MACHINES, INC.
|
|
|
Automated Sample Preparation for Next Generation Sequencing Cancer Diagnostics
|
1R43CA165372-01A1
|
$240,201
|
$240,201
|
Trotta, Nicholas
|
ADVANCED LIQUID LOGIC
|
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-05
|
$1,806,651
|
$1,806,651
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
|
Innovative high throughput tunable filter for widefield biomedical Raman imaging
|
1R43CA171740-01A1
|
$246,228
|
$246,228
|
ZHU, LEYUN
|
AGILTRON, INC.
|
|
|
Regulation of MMP-9 mRNA stability and tumor growth by alpha3 beta1 integrin
|
5R01CA129637-05
|
$230,410
|
$230,410
|
DIPERSIO, C. MICHAEL
|
ALBANY MEDICAL COLLEGE
|
|
|
Paracrine regulation of angiogenesis through integrin crosstalk
|
1F31CA174198-01A1
|
$26,232
|
$26,232
|
Longmate, Whitney
|
ALBANY MEDICAL COLLEGE
|
|
|
Concerted role for integrin alpha3beta1 and TGFb signaling in cancer progression
|
5F32CA153976-03
|
$55,670
|
$55,670
|
Subbaram, Sita
|
ALBANY MEDICAL COLLEGE
|
|
|
The Role of ATF3 in the DNA Damage Response
|
5R01CA139107-04
|
$239,147
|
$239,147
|
Yan, Chunhong
|
ALBANY MEDICAL COLLEGE
|
|
|
Screening Assays for Small Molecules Targeting Oncogenic eIF4E Expression
|
5R01CA164006-02
|
$277,361
|
$277,361
|
Yan, Chunhong
|
ALBANY MEDICAL COLLEGE
|
|
|
Women's Interagency HIV Study (WIHS-V)
|
2U01AI035004-20
|
$144,370
|
$144,370
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Developing Rwandan Research Capacity in Cervical Cancer and other AIDS Malignanci
|
3D43CA153793-03S1
|
$233,329
|
$233,329
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Central Africa IeDEA
|
5U01AI096299-03
|
$73,500
|
$73,500
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
The Feasibility of a Peer-Driven Pap Testing Intervention for Young Bronx Women
|
1R21CA169960-01A1
|
$218,255
|
$218,255
|
BAUMAN, LAURIE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Signal Transduction & Actin During Amoeboid Chemotaxis
|
5R01CA150344-25
|
$332,597
|
$332,597
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Tumor microenvironments determing migration, dissemination and dormancy
|
5U54CA163131-03
|
$908,453
|
$908,453
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
|
1R01CA167839-01A1
|
$346,525
|
$346,525
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Genetic analysis of the P13K/Akt pathway in thyroid benign and malignant disease
|
5R01CA128943-05
|
$314,070
|
$314,070
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
DNA Mismatch repair and cancer in murine models
|
2R01CA076329-16
|
$378,637
|
$378,637
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
|
5R01CA148966-04
|
$735,147
|
$735,147
|
EINSTEIN, MARK
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
The role of macroH2A variants in cancer and senescence
|
5R01CA155232-02
|
$325,734
|
$325,734
|
GAMBLE, MATTHEW
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Systems microscopy analysis of tumor cell motility in microenvironment context
|
1K99CA172360-01
|
$140,395
|
$140,395
|
Gligorijevic, Bojana
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Core Support for Cancer Center
|
2P30CA013330-40
|
$3,589,611
|
$3,589,611
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Core Support for Cancer Center
|
3P30CA013330-40S1
|
$75,000
|
$75,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Proton-coupled folate/antifolate transport
|
5R01CA082621-15
|
$479,143
|
$479,143
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Center for AIDS Research (CFAR)
|
3P30AI051519-10S1
|
$124,339
|
$124,339
|
GOLDSTEIN, HARRIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
EMT, Extravasation and metastasis by N-Cadherin signaling
|
5R01CA135061-05
|
$248,591
|
$248,591
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
R-Cadherin in Breast Cancer Suppression
|
5R01CA136854-05
|
$314,070
|
$314,070
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Taxol: Mechanisms of Action and Resistance
|
5R01CA077263-13
|
$378,397
|
$378,397
|
HORWITZ, SUSAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Targeting PML for therapy in leukemia-initiating cells
|
5R00CA139009-04
|
$234,060
|
$234,060
|
Ito, Keisuke
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Role of miRNA-375 in Invasive Phenotype of Head and Neck Squamous Cell Carcinoma
|
5F31CA168337-02
|
$54,871
|
$54,871
|
Jimenez, Lizandra
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Methods to Identify High-Affinity Antibodies that Target Tumor-Associated Glycans
|
5R21CA155472-03
|
$195,440
|
$195,440
|
Lai, Jonathan
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Lectimers: Glycan-anchored scaffold libraries for targeting carbohydrate-binding
|
1R21CA182330-01
|
$277,220
|
$277,220
|
LEVY, MATTHEW
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Targeting Cancer Cells with Functionalized Nanoparticle Libraries
|
5R21CA157366-03
|
$165,492
|
$165,492
|
LEVY, MATTHEW
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis
|
5R01CA170911-02
|
$325,734
|
$325,734
|
Libutti, Steven
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Chemical Modulation of Orphan Nuclear Receptor Function
|
3R01CA127231-05S1
|
$65,131
|
$65,131
|
MANI, SRIDHAR
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Total relevant funding to Cancer for this search: $4,787,897,881
|
